Bioassay for Insulin formulations
The invention relates to a bioassay of insulin peptide in oral formulations and low affinity insulin peptides in liquid formulations, by for quantifying phosphorylated Akt, thereby avoiding the interference of excipients in potency determination.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
28.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to a bioassay of insulin peptide in oral formulations and low affinity insulin peptides in liquid formulations, by for quantifying phosphorylated Akt, thereby avoiding the interference of excipients in potency determination. |
---|---|
Bibliography: | Application Number: US201716335060 |